Literature DB >> 6610515

Development of pre-B and B lymphocytes in the human fetus.

G E Asma, R Langlois van den Bergh, J M Vossen.   

Abstract

Cell suspensions from human fetal liver, bone marrow and spleen were systematically studied at between the fetal ages of 8 and 20 weeks by the direct immunofluorescence technique for the presence of pre-B and B cells. Pre-B cells were characterized as lymphoid cells containing cytoplasmic mu heavy chains but lacking surface IgM. Based on their size and morphological appearance, these cells were subdivided into large and small pre-B cells. In the livers of 8 week old fetuses, more than 90% of the total pre-B plus B cell population consisted of pre-B cells; the relative number of liver pre-B cells gradually decreased with increasing gestational age and, after the 14th week, B cells outnumbered pre-B cells. At 20 weeks, the ratio of pre-B to B cells was only 0.25. In contrast, the number of pre-B cells in fetal bone marrow (12-20 weeks) was always greater than that of the B cells. Large and small pre-B cells were present in the liver and bone marrow. Small pre-B cells outnumbered the large ones in both organs and with increasing gestational age the ratio of small to large pre-B cells increased four-fold. In fetal spleen (12-20 weeks), no large pre-B cells were seen and the small ones comprised only a minor fraction of the total B-cell population. It can be concluded from these data that during early human fetal life the liver is an important site of pre-B cell production. From 12 weeks onwards, this function is gradually taken over by the bone marrow. During the second half of pregnancy, pre-B cell production in fetal liver becomes very much less as compared with the bone marrow. No generation of pre-B cells takes place in the fetal spleen, but a certain amount of maturation of cells of the B cell line may take place in this organ.

Entities:  

Mesh:

Year:  1984        PMID: 6610515      PMCID: PMC1536228     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

Review 1.  B-lymphocyte subpopulations in the mouse. Organ distribution and ontogeny of immunoglobulin-synthesizing and of mitogen-sensitive cells.

Authors:  F Melchers; H Von Boehmer; R A Phillips
Journal:  Transplant Rev       Date:  1975

2.  Effect of prostaglandin synthesis on renal function and renin in the dog.

Authors:  P M Bolger; G M Eisner; P W Ramwell; L M Slotkoff
Journal:  Nature       Date:  1976-01-22       Impact factor: 49.962

3.  Studies on the generation of B lymphocytes in fetal liver and bone marrow.

Authors:  J J Owen; D E Wright; S Habu; M C Raff; M D Cooper
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

4.  Ontogeny of the antibody-forming cell line in mice. IV. Appearance of cells bearing Fc receptors, complement receptors, and surface immunoglobulin.

Authors:  Y J Rosenberg; C R Parish
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

5.  Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans.

Authors:  W E Gathings; A R Lawton; M D Cooper
Journal:  Eur J Immunol       Date:  1977-11       Impact factor: 5.532

6.  Expression of immunoglobin G on blood lymphocytes in chronic lymphocytic leukaemia.

Authors:  H S Dhaliwal; N R Ling; S Bishop; H Chapel
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

7.  An immunofluorescence procedure for the detection of intracellular immunoglobulins.

Authors:  W Hijmans; H R Schuit; F Klein
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

8.  Studies on the generation of B lymphocytes in the mouse embryo.

Authors:  J J Owen; M C Raff; M D Cooper
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

9.  Appearance of functional lymphocytes in fetal liver.

Authors:  R A Phillips; F Melchers
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

10.  B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states.

Authors:  E R Pearl; L B Vogler; A J Okos; W M Crist; A R Lawton; M D Cooper
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

View more
  7 in total

1.  A phenotypic study of B lymphocyte subpopulations in human bone marrow.

Authors:  M R Chapple; I C MacLennan; G D Johnson
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

2.  Fetal and neonatal development of human spleen: an immunohistological study.

Authors:  W Timens; T Rozeboom; S Poppema
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

3.  Characterization of early lymphoid precursor cells in the human fetus using monoclonal antibodies and anti-terminal deoxynucleotidyl transferase.

Authors:  G E Asma; R L van den Bergh; J M Vossen
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

4.  Usage of TCRAV and TCRBV gene families in human fetal and adult TCR rearrangements.

Authors:  F M Raaphorst; J van Bergen; R L van den Bergh; M van der Keur; R de Krijger; J Bruining; M J van Tol; J M Vossen; P J van den Elsen
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

Review 5.  Increasing Complexity of Molecular Landscapes in Human Hematopoietic Stem and Progenitor Cells during Development and Aging.

Authors:  Suzanne M Watt; Peng Hua; Irene Roberts
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

6.  Associations of maternal and infant metabolomes with immune maturation and allergy development at 12 months in the Swedish NICE-cohort.

Authors:  Olle Hartvigsson; Malin Barman; Hardis Rabe; Anna Sandin; Agnes E Wold; Carl Brunius; Ann-Sofie Sandberg
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

Review 7.  The Origin of B-cells: Human Fetal B Cell Development and Implications for the Pathogenesis of Childhood Acute Lymphoblastic Leukemia.

Authors:  Thomas R Jackson; Rebecca E Ling; Anindita Roy
Journal:  Front Immunol       Date:  2021-02-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.